| USD millions | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.3 | 0.6 | 1.1 | 2.5 | 1.6 | 1.2 | −23.0% | |
| Cost of revenue | 0.7 | 0.8 | 0.9 | 2.8 | 1.4 | 1.1 | −18.0% | |
| Gross profit | (0.4) | (0.2) | 0.2 | (0.3) | 0.2 | 0.1 | −63.8% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Selling, general & administrative | 1.6 | 1.6 | 13.9 | 18.2 | 11.6 | — | — | |
| Selling & marketing | 0.5 | 0.7 | 2.5 | 3.6 | 0.6 | — | — | |
| Operating expenses | 1.6 | 1.6 | 15.8 | 18.2 | 11.6 | 11.0 | −5.1% | |
| Operating income | (2.0) | (1.8) | (15.6) | (18.5) | (11.4) | (11.0) | +4.2% | |
| Interest expense | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.3 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other income / expense | 0.0 | 0.0 | (0.2) | (4.3) | (14.1) | — | — | |
| Pre-tax income | (2.0) | (1.8) | (15.7) | (22.8) | (25.5) | (19.1) | +25.0% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (2.0) | (1.8) | (15.7) | (22.8) | (25.5) | (19.2) | +24.9% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (19,904.00) | (18,682.00) | (59,547.00) | (14,433.00) | (351.00) | (12.44) | +96.5% | |
| EPS, diluted (per share) | (19,904.00) | (18,682.00) | (59,547.00) | (14,433.00) | (351.00) | (12.44) | +96.5% | |
| EBITDA | (1.8) | (1.6) | (15.4) | (22.8) | (25.5) | (8.9) | +65.1% | |
| Depreciation & amortization | 0.2 | 0.3 | 0.2 | 0.0 | 0.0 | — | — | |
| Weighted average shares (shares) | 99 | 99 | 264 | 1,577 | 72,815 | — | — | |
| Weighted average diluted shares (shares) | 99 | 99 | 264 | 1,577 | 72,815 | — | — | |
| Gross margin | −114.9% | −33.6% | 18.3% | −12.5% | 10.8% | 5.1% | −5.7 pts | |
| Operating margin | −622.5% | −306.5% | −1,390.0% | −739.0% | −730.3% | −908.3% | −177.9 pts | |
| Net margin | −622.5% | −306.5% | −1,405.3% | −909.6% | −1,631.0% | −1,589.2% | +41.8 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
